TGEN-001

N/A

Report date: 2026/03/30 17:02:26

Base Information

Drug NameTGEN-001
Drug Alias NameTGEN-001 derivatives (Transposagen)TGEN-001
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionShort transient receptor potential channel 4 modulators
TargetsShort transient receptor potential channel 4
Therapy Area/IndicationsPain
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPending (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesTransposagen Biopharmaceuticals Inc
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesTransposagen Biopharmaceuticals Inc
Active IndicationsN/A
Inactive IndicationsPain

Other Information

ATC CodeN/A
Related LinksN/A